Two reports suggest that polymorphisms of the GR gene may be associated with metabolic profiles in 21-OHD patients: the BclI GR polymorphism, which is associated to increased GC sensitivity, was linked to increased cardiovascular risk among adult CAH-subjects [11]. The gene discussed is NR3C1; the disease is congenital adrenal hyperplasia.